Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Non Small Cell Lung Cancer|GastroEsophageal Cancer|Bladder Cancer
Interventions: DRUG: ADCT-502
Sponsor: ADC Therapeutics S.A.